Dorsey Wright & Associates Castle Biosciences Inc Transaction History

Dorsey Wright & Associates

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 23, 2021	SELL	$50.07 - $76.78 $30,943 - $47,450	-618 Closed	0 $0
Q1 2021 Apr 27, 2021	BUY	$58.92 - $97.33 $20,857 - $34,454	354 Added 134.09%	618 $42.3 Million
Q4 2020 Jan 28, 2021	BUY	$43.6 - $73.05 $2,877 - $4,821	66 Added 33.33%	264 $18,000
Q3 2020 Oct 28, 2020	SELL	$38.47 - $52.03 $2,539 - $3,433	-66 Reduced 25.0%	198 $10,000
Q2 2020 Jul 23, 2020	BUY	$27.28 - $43.01 $7,201 - $11,354	264 New	264 $10,000

162

25.3M

82.2K

150K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $559M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

Stay updated on Dorsey Wright & Associates with notifications on news.